Truist Financial Corp Sells 13,212 Shares of GE HealthCare Technologies Inc. $GEHC

Truist Financial Corp decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 17.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,687 shares of the company’s stock after selling 13,212 shares during the period. Truist Financial Corp’s holdings in GE HealthCare Technologies were worth $5,224,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. Empowered Funds LLC lifted its stake in GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares during the period. Acadian Asset Management LLC bought a new position in GE HealthCare Technologies during the first quarter worth about $259,000. Cresset Asset Management LLC raised its stake in shares of GE HealthCare Technologies by 12.5% in the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after acquiring an additional 865 shares during the last quarter. Jump Financial LLC raised its stake in shares of GE HealthCare Technologies by 317.6% in the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after acquiring an additional 21,396 shares during the last quarter. Finally, Gamco Investors INC. ET AL raised its stake in shares of GE HealthCare Technologies by 8.6% in the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after acquiring an additional 320 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $63.47 on Monday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The company has a 50 day moving average price of $71.92 and a 200 day moving average price of $77.34. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The stock has a market capitalization of $28.87 billion, a PE ratio of 15.18, a price-to-earnings-growth ratio of 1.43 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter last year, the firm earned $1.01 EPS. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.35%.

Insider Buying and Selling

In related news, CFO James Saccaro acquired 3,310 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Frank R. Jimenez acquired 1,750 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average price of $60.45 per share, with a total value of $105,787.50. Following the transaction, the insider directly owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased 9,229 shares of company stock worth $556,180 in the last quarter. Insiders own 0.36% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on GEHC shares. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Stifel Nicolaus set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. Oppenheimer reiterated an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Rothschild & Co Redburn cut their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Finally, Citigroup cut their target price on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Eight equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $80.67.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.